Vericel earnings were $13.1M for the trailing 12 months ending Sep 30, 2025, with 271.4% growth year over year. The latest VCEL earnings report on Sep 30, 2025 announced Q3 2025 earnings of $5.1M, down 1,017.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, VCEL reported annual earnings of $10.4M, with -425.6% growth.
VCEL past earnings growth
How has VCEL's earnings growth performed historically?
On VCEL's earnings call on Invalid Date, Vericel (NASDAQ: VCEL) reported Q3 2025 earnings per share (EPS) of $0.10, up 600% year over year. Total VCEL earnings for the quarter were $5.07 million. In the same quarter last year, Vericel's earnings per share (EPS) was -$0.02.
As of the last Vericel earnings report, Vericel is currently profitable. Vericel's net profit (also called net income) for the twelve months ending Sep 30, 2025 was $13.08 million, a 268.71% increase year over year.
What was VCEL's earnings growth in the past year?
As of Vericel's earnings date in Invalid Date, Vericel's earnings has grown 271.43% year over year. This is 209.49 percentage points higher than the US Biotechnology industry earnings growth rate of 61.94%. VCEL earnings in the past year totalled $13.08 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.